Signaling another year of momentum as the clinical‑first primary care technology company accelerates AI‑powered primary care innovation, adoption, and partnershipsSignaling another year of momentum as the clinical‑first primary care technology company accelerates AI‑powered primary care innovation, adoption, and partnerships

Elation Health 2025 Year-End Highlights: Growth, Platform Expansion, and Real-World Impact

2025/12/16 22:30
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Signaling another year of momentum as the clinical‑first primary care technology company accelerates AI‑powered primary care innovation, adoption, and partnerships

SAN FRANCISCO–(BUSINESS WIRE)–Elation Health, the clinical‑first technology company powering innovation in primary care, today celebrated 2025 key growth milestones, including accelerated innovation, clinician adoption, and recognition.

“2025 showed what’s possible for primary care,” said Kyna Fong, Ph.D., co-founder and CEO of Elation Health. “We began the year earning Best in KLAS for our EHR/PM platform, the first year we were eligible since the integration of our Billing system, and carried that momentum into the work we’ve been doing to transform primary care workflows with AI-powered solutions. We’ve stayed true to our mission to support clinicians’ success, continuing to innovate and deliver faster than ever. Together with our clinician partners, we’ve rolled out new features that support ALL types of primary care models, making high-quality care more accessible and sustainable, and setting the stage for powerful, game-changing solutions in 2026.”

2025 Elation Health highlights include:

  • Executive growth: Ashley Rogers, previously at Evolent, has joined as Chief Product Officer to lead Elation’s primary care innovation roadmap in 2026.
  • Clinical‑First AI platform impact: Elation launched new embedded AI-native features for customers at no additional cost, introduced with a video featuring Fong and Vice President of Engineering Phill Tornroth. Adoption has rapidly increased among active clinicians since the August launch, led by Note Assist and Actions, with a strong uptake of Wordsmith, Medication Reconciliation, and clinical decision making supported by Clinical Insights. 76% of clinicians said Elation’s intelligent features help them deliver better care; 61% reported reduced stress/burnout, saving ~12 minutes per visit (~2 hours/day); 67% reported more joy in their work in select surveys.
  • Industry recognition: Elation was named Best in KLAS 2025, #1 Small Practice Ambulatory EHR/PM: Independent (1–10 Physicians) and #1 EHR‑Centric Virtual Care Platform, reaffirming Elation’s trusted, clinical-first experience in primary care and joined TIME World’s Top HealthTech Companies of 2025.
  • Addressing care for ALL primary care populations: The company launched new tools for pediatrics in the Fall, including a weight‑based dosing calculator, embedded pediatric screeners, age‑based well‑child templates (0–18), and refined growth charts, further supporting clinicians who care for children, teens, and families.
  • Seoul Medical Group partnership: The company announced a collaboration to support independent primary care across SMG’s national network – the largest Korean-American-focused IPA, serving 100,000+ patients and 5,000+ providers across seven U.S. markets – with dedicated onboarding, integrated workflows, and co‑marketing enablement.
  • National interoperability leadership: Elation joined the CMS Health Tech Ecosystem and CEO Fong was invited to the White House to celebrate the industry’s advancements and progress towards eliminating the clipboard for clinicians and patients.
  • Rapid release, responsible innovation: The company accelerated its release cadence in 2025, pushing hundreds of enhancements into production, accelerating practice impact while upholding safety, validation, and transparency.

To learn more about the platform for primary care success or request a demo, please visit elationhealth.com.

About Elation Health

Elation Health is the clinical-first AI platform for primary care success. Trusted by over 46,000 clinical users caring for 23 million patients, Elation’s EHR and billing solutions combine proven clinical workflows with responsible AI, purpose-built for primary care. The company’s clinical-first approach puts patient care at the center, delivering trusted, transparent innovation that saves physicians time and sustains meaningful patient relationships. Elation Health is recognized as Best in KLAS for its commitment to excellence in primary care technology. Learn more at elationhealth.com and on LinkedIn.

Contacts

media@elationhealth.com

Market Opportunity
RealLink Logo
RealLink Price(REAL)
$0.0576
$0.0576$0.0576
+0.73%
USD
RealLink (REAL) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

SEC Backs Nasdaq, CBOE, NYSE Push to Simplify Crypto ETF Rules

SEC Backs Nasdaq, CBOE, NYSE Push to Simplify Crypto ETF Rules

The US SEC on Wednesday approved new listing rules for major exchanges, paving the way for a surge of crypto spot exchange-traded funds. On Wednesday, the regulator voted to let Nasdaq, Cboe BZX and NYSE Arca adopt generic listing standards for commodity-based trust shares. The decision clears the final hurdle for asset managers seeking to launch spot ETFs tied to cryptocurrencies beyond Bitcoin and Ether. In July, the SEC outlined how exchanges could bring new products to market under the framework. Asset managers and exchanges must now meet specific criteria, but will no longer need to undergo drawn-out case-by-case reviews. Solana And XRP Funds Seen to Be First In Line Under the new system, the time from filing to launch can shrink to as little as 75 days, compared with up to 240 days or more under the old rules. “This is the crypto ETP framework we’ve been waiting for,” Bloomberg research analyst James Seyffart said on X, predicting a wave of new products in the coming months. The first filings likely to benefit are those tracking Solana and XRP, both of which have sat in limbo for more than a year. SEC Chair Paul Atkins said the approval reflects a commitment to reduce barriers and foster innovation while maintaining investor protections. The move comes under the administration of President Donald Trump, which has signaled strong support for digital assets after years of hesitation during the Biden era. New Standards Replace Lengthy Reviews And Repeated Denials Until now, the commission reviewed each application separately, requiring one filing from the exchange and another from the asset manager. This dual process often dragged on for months and led to repeated denials. Even Bitcoin spot ETFs, finally approved in Jan. 2024, arrived only after years of resistance and a legal battle with Grayscale. According to Bloomberg ETF analyst Eric Balchunas, the streamlined rules could apply to any cryptocurrency with at least six months of futures trading on the Coinbase Derivatives Exchange. That means more than a dozen tokens may now qualify for listing, potentially unleashing a new wave of altcoin ETFs. SEC Clears Grayscale Large Cap Fund Tracking CoinDesk 5 Index The SEC also approved the Grayscale Digital Large Cap Fund, which tracks the CoinDesk 5 Index, including Bitcoin, Ether, XRP, Solana and Cardano. Alongside this, it cleared the launch of options linked to the Cboe Bitcoin US ETF Index and its mini contract, broadening the set of crypto-linked derivatives on regulated US markets. Analysts say the shift shows how far US policy has moved. Where once regulators resisted digital assets, the latest changes show a growing willingness to bring them into the mainstream financial system under established safeguards
Share
CryptoNews2025/09/18 12:40
How a 35-Year-Old Crypto Bro Help Pakistan Win Trump World

How a 35-Year-Old Crypto Bro Help Pakistan Win Trump World

The post How a 35-Year-Old Crypto Bro Help Pakistan Win Trump World appeared on BitcoinEthereumNews.com. Bloomberg said Bilal Bin Saqib helped Pakistan build ties
Share
BitcoinEthereumNews2026/03/31 08:55
Key Reason Why Strategy Didn’t Buy Any Bitcoin (BTC)

Key Reason Why Strategy Didn’t Buy Any Bitcoin (BTC)

The post Key Reason Why Strategy Didn’t Buy Any Bitcoin (BTC) appeared on BitcoinEthereumNews.com. Strategy, the largest corporate holder of Bitcoin, has uncharacteristically
Share
BitcoinEthereumNews2026/03/31 08:45